Relevance of the pharmacokinetic profile in the treatment of angina pectoris: the need for 24 h control

Eur Heart J. 1995 Jul:16 Suppl E:57-61. doi: 10.1093/eurheartj/16.suppl_e.57.
No abstract available

Publication types

  • Review

MeSH terms

  • Angina Pectoris / drug therapy*
  • Angina Pectoris / metabolism
  • Calcium Channel Blockers / pharmacokinetics
  • Calcium Channel Blockers / therapeutic use
  • Cardiovascular Agents / pharmacokinetics*
  • Cardiovascular Agents / therapeutic use*
  • Humans
  • Myocardial Ischemia / metabolism

Substances

  • Calcium Channel Blockers
  • Cardiovascular Agents